E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Morris, Gerwyn, Berk, Michael, Walder, Ken et al. · BMC medicine · 2015 · DOI
Quick Summary
This review proposes that ME/CFS fatigue may be caused by ongoing inflammation and immune system activation in the body, which then damages the brain's support cells (astrocytes) and energy-producing structures (mitochondria). The authors suggest that ME/CFS shares similar biological mechanisms with other inflammatory diseases like multiple sclerosis and lupus, and recommend that ME/CFS patients be tested for immune activation and receive specific brain imaging to look for evidence of inflammation.
Why It Matters
This study provides a testable mechanistic framework linking ME/CFS to measurable biological markers of inflammation and immune activation, supporting the view that ME/CFS is a biological illness rather than psychological. It suggests concrete diagnostic approaches (immune testing, FLAIR MRI) and identifies specific cellular targets (astrocytes, mitochondria) that could guide future therapeutic development for ME/CFS patients.
Observed Findings
- Elevated proinflammatory cytokines, oxidative stress, and Toll-like receptor activation are present in ME/CFS patients similar to other neuroinflammatory diseases.
- Gray matter atrophy, glucose hypometabolism, and cerebral hypoperfusion correlate with the degree of peripheral immune activation in neuroinflammatory disease.
- Mitochondrial dysfunction is widespread in otherwise normal tissue in ME/CFS and related neuroinflammatory conditions.
- Astrocyte numbers and function are reduced in neuroinflammatory diseases in association with peripheral immune activation.
Inferred Conclusions
- Peripheral immune activation and inflammation likely drive glial cell dysfunction and mitochondrial damage, explaining severe intractable fatigue in ME/CFS.
- ME/CFS shares common neuroimmune and neuroimmunological mechanisms with MS, Parkinson's disease, and autoimmune conditions.
- ME/CFS patients should be evaluated for peripheral immune activation using FLAIR MRI and immune biomarker testing to confirm the inflammatory hypothesis.
Remaining Questions
- Does peripheral immune activation directly cause astrocyte dysfunction in ME/CFS, or is this association correlational?
- Which specific proinflammatory cytokines or immune markers are most predictive of fatigue severity in ME/CFS populations?
What This Study Does Not Prove
This review does not establish causation—it identifies associations and proposes mechanisms without direct experimental evidence in ME/CFS populations. It does not prove that astrocyte dysfunction or mitochondrial damage in ME/CFS is primary rather than secondary, nor does it validate the proposed diagnostic tests as reliable biomarkers in ME/CFS specifically. The framework remains theoretical pending confirmation in ME/CFS-specific cohorts.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesNeuroimaging
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1186/s12916-014-0259-2
- PMID
- 25856766
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →